A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) ...

The two studies – in younger children aged 2 to 6 and older subjects in the 7 to 17 age group, respectively – failed to show any improvement with bumetanide on the main childhood autism rating ...

A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...

(www.corstasis.com), a clinical-stage MedTech pharmaceutical company developing innovative, practical therapies for fluid overload, today announced that the U.S. Food and Drug Administration (FDA) has ...

US speciality chemicals company Gabriel Performance Products (Ashtabula, Ohio; www.gabrielchem.com) has bought the phenoxy resin business of Inchem Corporation (Rock Hill, South Carolina / USA; ...

Otto Diels-Institut für Organische Chemie, Christian-Albrechts-Universität zu Kiel, Otto-Hahn-Platz 4, 24118 Kiel, Germany ...

His group uses computational tools to analyze the structural chemistry of disease associated and understudied target classes and to accelerate the discovery and optimization of open science chemical ...